Our top pick for
CRH Medical Corporation is a medical instruments & supplies business based in the US. CRH Medical Corporation shares (CRHM) are listed on the NYSE MKT and all prices are listed in US Dollars. CRH Medical Corporation employs 149 staff and has a trailing 12-month revenue of around USD$99.8 million.
|Latest market close||USD$2.33|
|52-week range||USD$0.86 - USD$4.4|
|50-day moving average||USD$2.6815|
|200-day moving average||USD$2.38|
|Wall St. target price||USD$3.4|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||USD$0.024|
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
|1 week (2021-01-11)||7.37%|
|1 month (2020-12-18)||-18.82%|
|3 months (2020-10-16)||6.39%|
|6 months (2020-07-17)||2.19%|
|1 year (2020-01-17)||-42.47%|
|2 years (2019-01-18)||-28.75%|
|3 years (2018-01-18)||2.75|
|5 years (2016-01-15)||2.37|
Valuing CRH Medical Corporation stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of CRH Medical Corporation's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
CRH Medical Corporation's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 40x. In other words, CRH Medical Corporation shares trade at around 40x recent earnings.
CRH Medical Corporation's EBITDA (earnings before interest, taxes, depreciation and amortisation) is USD$30.8 million.
The EBITDA is a measure of a CRH Medical Corporation's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||USD$99.8 million|
|Gross profit TTM||USD$21.6 million|
|Return on assets TTM||-2.41%|
|Return on equity TTM||-2.6%|
|Market capitalisation||USD$156.2 million|
TTM: trailing 12 months
There are currently 4,389 CRH Medical Corporation shares held short by investors – that's known as CRH Medical Corporation's "short interest". This figure is 12.5% down from 5,017 last month.
There are a few different ways that this level of interest in shorting CRH Medical Corporation shares can be evaluated.
CRH Medical Corporation's "short interest ratio" (SIR) is the quantity of CRH Medical Corporation shares currently shorted divided by the average quantity of CRH Medical Corporation shares traded daily (recently around 73150). CRH Medical Corporation's SIR currently stands at 0.06. In other words for every 100,000 CRH Medical Corporation shares traded daily on the market, roughly 60 shares are currently held short.
However CRH Medical Corporation's short interest can also be evaluated against the total number of CRH Medical Corporation shares, or, against the total number of tradable CRH Medical Corporation shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case CRH Medical Corporation's short interest could be expressed as 0% of the outstanding shares (for every 100,000 CRH Medical Corporation shares in existence, roughly 0 shares are currently held short) or 0.0001% of the tradable shares (for every 100,000 tradable CRH Medical Corporation shares, roughly 0 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against CRH Medical Corporation.
Find out more about how you can short CRH Medical Corporation stock.
We're not expecting CRH Medical Corporation to pay a dividend over the next 12 months.
Over the last 12 months, CRH Medical Corporation's shares have ranged in value from as little as $0.86 up to $4.4. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE MKT average) beta is 1, while CRH Medical Corporation's is 2.7778. This would suggest that CRH Medical Corporation's shares are significantly more volatile than the average for this exchange and represent a higher risk.
CRH Medical Corporation provides anesthesia services for patients undergoing endoscopic procedures in the United States and Canada. It offers CRH O'Regan system, a single use, disposable, and hemorrhoid banding technology to treat various grades of hemorrhoid. The company also distributes CRH O'Regan system, treatment protocols, and operational and marketing expertise as a turnkey package directly to physicians. It serves 65 ambulatory surgical/endoscopy centers in 13 states. The company was formerly known as Medsurge Medical Products Corp. and changed its name to CRH Medical Corporation in April 2006. CRH Medical Corporation was incorporated in 2001 and is headquartered in Vancouver, Canada.
Everything we know about the CDT Environmental Technology Investment Holdings Limited IPO, plus information on how to buy in.
Everything we know about the Viant Technology Inc IPO, plus information on how to buy in.
Steps to owning and managing EVGN, with 24-hour and historical pricing before you buy.
Steps to owning and managing ETL, with 24-hour and historical pricing before you buy.
Steps to owning and managing EQBK, with 24-hour and historical pricing before you buy.
Steps to owning and managing EIGI, with 24-hour and historical pricing before you buy.
Steps to owning and managing ELTK, with 24-hour and historical pricing before you buy.
Steps to owning and managing DNKN, with 24-hour and historical pricing before you buy.
Steps to owning and managing DKL, with 24-hour and historical pricing before you buy.
Steps to owning and managing DMAC, with 24-hour and historical pricing before you buy.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.